William Blair Downgrades St. Jude Medical (STJ) to Market Perform

Go back to William Blair Downgrades St. Jude Medical (STJ) to Market Perform

Credit Suisse Downgrades St. Jude Medical (STJ) to Neutral Follower Takeout

May 3, 2016 6:27 AM EDT

Credit Suisse downgraded St. Jude Medical (NYSE: STJ) from Outperform to Neutral with a price target of $81.00 (from $67.00) after the company agreed to be acquired by Abbott.

For an analyst ratings summary and ratings history on St. Jude Medical... More

Needham & Company Downgrades St. Jude Medical (STJ) to Hold Following Takeover

April 29, 2016 7:15 AM EDT

Needham & Company downgraded St. Jude Medical (NYSE: STJ) from Buy to Hold after the company agreed to be acquired by Abbott.

Analyst Mike Matson commented, "After Abbott (ABT) denied a report last summer in the Financial Times that it was... More